NI Medicines Optimisation Innovation Centre of Excellence

Sub-optimal medicines use is a challenge globally, contributing to poorer health outcomes, inefficiencies and waste. The MOIC – Medicines Optimisation Innovation Centre was established in Northern Ireland by the Department of Health NI in 2015 to support implementation of the Medicines Optimisation Quality Framework. It is a dedicated centre driving innovation in medicines optimisation impact and sustainability. 

An article on how MOIC informs policy and provides support to commissioners to improve population health and wellbeing has been recently published in the International Journal of Clinical Pharmacy: “MOIC has demonstrated considerable success and sustainability, driving innovation and best practice in medicines use and associated technologies. Achieving extensive reach and recognition, MOIC is relevant and applicable to health systems and economies globally. 

“MOIC has established partnerships with academia, industry, healthcare and representative organisations across Europe, participating in research and development projects and testing integrated technology solutions. A hosting programme has been established and evaluation and dissemination strategies have been developed. 

“MOIC has established numerous agreements, partnered in three large EU projects and strengthened networks globally with extensive publications and conference presentations. Informing pathway redesign, sustainability and COVID response, MOIC has also assisted in the development of clinical pharmacy services and antimicrobial stewardship in Europe and Africa. 

“Northern Ireland has now been recognised as a 4-star European Active and Healthy Ageing Reference Site and the Integrated Medicines Management model as an example of best practice in Central and Eastern Europe.”

Related News

mRNA vaccine company, pHion Therapeutics, announced a joint Innovate UK award with Queen’s University Belfast. The £1million grant will fund…

Pictured (L-R) are Professor Ian Greer, Vice-Chancellor, Queen’s University Belfast; Dr. Robert Ladner, CEO, CV6; Mel Chittock, Interim CEO, Invest…

HIRANI shines a spotlight on one of the first therapeutic bio-techs to spin out of Queen’s University Belfast. Founder and…

Disrupting into the next chapter

Health Tech Spring 2024 provides a stage for thought leaders and influential speakers in healthcare.

Learn how we helped 100 top brands gain success